Radojka M. Savić

MedicineComputer SciencePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens”.

Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens

Nature Communications(2021)10.1038/s41467-021-22833-6

N/A

2.0DataRank · unranked

98 citations

Sarah E. M. Born, Gregory T. Robertson, Matthew J. Reichlen, Christian Dide-Agossou, Victoria Ektnitphong +36 more

Randomized Clinical Trial of High-Dose Rifampicin With or Without Levofloxacin Versus Standard of Care for Pediatric Tuberculous Meningitis: The TBM-KIDS Trial

Clinical Infectious Diseases(2022)10.1093/cid/ciac208

N/A

1.5DataRank · unranked

40 citations

Bella Devaleenal D, Tisungane Mvalo, Ana Arenivas, Kiran T. Thakur, Lisa Wolf +95 more

Optimising pyrazinamide for the treatment of tuberculosis

European Respiratory Journal(2021)10.1183/13993003.02013-2020

N/A

1.4DataRank · unranked

36 citations

Radojka M. Savić, Martin J. Boeree, Charles A. Peloquin, Marc Weiner, Norbert Heinrich +11 more

Early Bactericidal Activity Trial of Nitazoxanide for Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01956-19

N/A

1.1DataRank · unranked

31 citations

Katherine McAulay, Miroku Lee, Stalz Charles Vilbrun, L Mathurin, Daphie Francois +12 more

Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01794-20

N/A

0.571DataRank · unranked

12 citations

Belén P. Solans, William R. Mac Kenzie, Chad Heilig, William C. Whitworth, John L. Johnson +5 more

Strategies for shortening tuberculosis therapy

Nature Medicine(2025)10.1038/s41591-025-03742-3

N/A

0.542DataRank · unranked

36 citations

Valerie Mizrahi, Radojka M. Savić, Jared Silverman, David Hermann, Clifton E. Barry +1 more

Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.00506-21

N/A

0.533DataRank · unranked

34 citations

Jansy P. Sarathy, Ning Wang, Firat Kaya, Matthew Zimmerman, Natasha Strydom +9 more

Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01705-21

N/A

0.526DataRank · unranked

7 citations

Jacqueline P. Ernest, Nan Zhang, Nicole C. Ammerman, Eric L. Nuermberger, Robert Belknap +4 more

Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis

PLoS Computational Biology(2020)10.1371/journal.pcbi.1008107

N/A

0.505DataRank · unranked

28 citations

Natasha Strydom, William S. Fox, Ron J. Keizer, Radojka M. Savić, John Fors

Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01013-20

N/A

0.480DataRank · unranked

8 citations

Marjorie Z. Imperial, Erika Wallender, Richard Kajubi, Liusheng Huang, Prasanna Jagannathan +16 more

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis

Clinical Infectious Diseases(2024)10.1093/cid/ciae119

N/A

0.306DataRank · unranked

6 citations

Ava Y Xu, Gustavo E. Velásquez, Nan Zhang, Vincent Chang, Ekaterina V. Kurbatova +16 more

Drug concentration at the site of disease in children with pulmonary tuberculosis

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac103

N/A

0.292DataRank · unranked

6 citations

Ahmed A. Abulfathi, Natasha Strydom, Pierre Goussard, Abraham C. van Wyk, Anne Marie Demers +16 more

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

Trials(2025)10.1186/s13063-025-08973-w

N/A

0.168DataRank · unranked

2 citations

Gustavo E. Velásquez, Russell R. Kempker, Marjorie Z. Imperial, Eric L. Nuermberger, Susan E. Dorman +22 more

Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine Models

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf088

N/A

0.104DataRank · unranked

1 citations

Lorenzo Flori, Rob C. van Wijk, Jacqueline P. Ernest, Sandeep Tyagi, Heena Soni +7 more

Lesion penetration predicts tuberculosis regimen success: a validated translational tool for de-risking late-stage drug development

Research Square(2025)10.21203/rs.3.rs-6890010/v1

N/A

0DataRank · unranked

0 citations

Jacqueline P. Ernest, Annamarie E. Bustion, Anu Patel, Jansy P. Sarathy, Firat Kaya +9 more

Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy Volunteers

UNC Libraries(2020)10.17615/48tz-4826

N/A

0DataRank · unranked

0 citations

Evelyn Hogg, Constance A. Benson, Kristine Y. Patterson, Jennifer Janik, Richard Hafner +8 more

Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children

Clinical Infectious Diseases(2021)10.1093/cid/ciab641

N/A

0DataRank · unranked

31 citations

Anneke C. Hesseling, Jana Winckler, Heather R. Draper, Belén P. Solans, Stephanie Thee +8 more

Characterizing HIV-Preventive, Plasma Tenofovir Concentrations—A Pooled Participant-level Data Analysis From Human Immunodeficiency Virus Preexposure Prophylaxis Clinical Trials

Clinical Infectious Diseases(2022)10.1093/cid/ciac313

N/A

0DataRank · unranked

22 citations

Katarina Vučićević, Craig W. Hendrix, Priya Jayachandran, Leah G. Jarlsberg, Robert M. Grant +10 more

A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.02212-21

N/A

0DataRank · unranked

21 citations

Jacqueline P. Ernest, Katherine LoMauro, Martin Gengenbacher, Abdeldjalil Madani, Wassihun Wedajo Aragaw +15 more

Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant Tuberculosis

Clinical Infectious Diseases(2022)10.1093/cid/ciac252

N/A

0DataRank · unranked

15 citations

Belén P. Solans, Heather R. Draper, H. Simon Schaaf, Jana Winckler, L. van der Laan +7 more

Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure

Clinical Infectious Diseases(2022)10.1093/cid/ciac001

N/A

0DataRank · unranked

12 citations

Adrie Bekker, Belén P. Solans, Mark F. Cotton, Mark Mirochnick, Avy Violari +8 more

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00284-23

N/A

0DataRank · unranked

34 citations

Jackie P. Ernest, Christian Dide-Agossou, Allison Bauman, Michelle E. Ramey, Karen Rossmassler +12 more

Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00794-23

N/A

0DataRank · unranked

9 citations

Belén P. Solans, Anneke C. Hesseling, Jana Winckler, H. Simon Schaaf, Heather R. Draper +8 more

Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis

CPT Pharmacometrics & Systems Pharmacology(2023)10.1002/psp4.12892

N/A

0DataRank · unranked

3 citations

Erika Wallender, Emma Hughes, Grant Dorsey, Radojka M. Savić, Ali M. Ali

Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.03.527062

N/A

0DataRank · unranked

0 citations

Jackie P. Ernest, Christian Dide-Agossou, Allison Bauman, Michelle E. Ramey, Karen Rossmassler +12 more

Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis

Clinical Infectious Diseases(2024)10.1093/cid/ciae024

N/A

0DataRank · unranked

13 citations

Belén P. Solans, Paolo Denti, Louvina E. van der Laan, H. Simon Schaaf, Bryan Vonasek +7 more

The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf303

N/A

0DataRank · unranked

6 citations

Jacqueline P. Ernest, Firat Kaya, Connie Silva, Jansy P. Sarathy, Landry Blanc +11 more